Chat with us, powered by LiveChat
  • Technology
  • Services
    • Drug Development Partnerships
      • Expand your drug discovery capacity, shoulder to shoulder with our scientific team. Proprietary human disease biology in the OrganoPlate® platform. Together we make the therapeutics of tomorrow.
    • Custom Model & Assay Development
      • We create novel human tissue and disease models in the OrganoPlate® platform. Our experts are looking forward to developing assays according to your specifications.
    • Compound profiling & Screening
      • Get robust compound data in human tissue models through our services. With proven pheno­typic assays in the OrganoPlate® platform, we support your drug discovery and development needs.
    • All Services
      • We offer several services to support your drug discovery and development needs. Find the overview here.
  • Products
  • Applications
    • Perfused Tubules

      • Layered tissues with perfused tubules in the absence of artificial membranes form the heart of our permeability and transport science. Study cell interactions, permeability, absorption, transport, and transcytosis without physical barriers.

    • Cell-Cell Interactions

      • Co-culture layered & structured tissues without artificial membranes with perfect imaging, to study barrier-free cellular interactions, cell-cell signaling, and migration.

    • 3D Cell Migration

      • Evaluate the effect of chemotactic triggers or cells on the migration of cells through an extracellular matrix.

    • Angiogenesis

      • Membrane-free microvascular formation and growth through an extracellular matrix (ECM).

    • Vascularization

      • The missing link in tissue culture: add perfusable human vasculature to your tissue models, and recreate sophisticated microenvironments with OrganoPlate® Graft.

    • All Applications

      • OrganoPlate® enables you to study relevant 3D tissue biology by incorporating perfused tubules, co-culture, and full control over the tissue microenvironment. Find the overview of applications here.

  • Resources & Support
    • Knowledge Center

      • Visit our Knowledge Center to get up to speed with 3D tissue culture and to learn how OrganoPlate® supports your research needs.

        Read our publications, application notes, watch our webinars, or check out the supporting protocols and brochures. All compiled for you, by our scientists.

    • Publications

      • Get inspired by peer-reviewed publications of our scientists, partners, and customers around the globe.

    • Case Studies

      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Workshops & Trainings
      • Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.
    • Technical Support
      • Any support questions about purchasing, products, or 3D tissue culture and analysis? Get in touch with our experts.
    • Request a quote

      • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

    • FAQ
      • Frequently asked questions answered by our experts. Find here the answer you're looking for.
  • Knowledge Center
  • About Mimetas
  • Expand your drug discovery capacity, shoulder to shoulder with our scientific team. Proprietary human disease biology in the OrganoPlate® platform. Together we make the therapeutics of tomorrow.
  • We create novel human tissue and disease models in the OrganoPlate® platform. Our experts are looking forward to developing assays according to your specifications.
  • Get robust compound data in human tissue models through our services. With proven pheno­typic assays in the OrganoPlate® platform, we support your drug discovery and development needs.
  • We offer several services to support your drug discovery and development needs. Find the overview here.
  • Start today with 3D tissue modeling
    Kickstart your first experiments with the OrganoPlate® through our OrganoStart packages.

  • OrganoFlow®
    Driving precisely-controlled perfusion flow in the OrganoPlate® platform

  • OrganoTEER®
    Enabling fast, automated, and impedance-based TEER measurements in OrganoPlate®. Assay 40 or 64 tissue culture chips with a few clicks, in less than two minutes.

  • Start today with 3D tissue modeling
    Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.

  • OrganoPlate® is the solution for all in vitro tissue culture applications. Explore the entire OrganoPlate® family and its dedicated instruments here.

  • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

  • Layered tissues with perfused tubules in the absence of artificial membranes form the heart of our permeability and transport science. Study cell interactions, permeability, absorption, transport, and transcytosis without physical barriers.

  • Co-culture layered & structured tissues without artificial membranes with perfect imaging, to study barrier-free cellular interactions, cell-cell signaling, and migration.

  • Evaluate the effect of chemotactic triggers or cells on the migration of cells through an extracellular matrix.

  • Membrane-free microvascular formation and growth through an extracellular matrix (ECM).

  • The missing link in tissue culture: add perfusable human vasculature to your tissue models, and recreate sophisticated microenvironments with OrganoPlate® Graft.

  • OrganoPlate® enables you to study relevant 3D tissue biology by incorporating perfused tubules, co-culture, and full control over the tissue microenvironment. Find the overview of applications here.

  • Visit our Knowledge Center to get up to speed with 3D tissue culture and to learn how OrganoPlate® supports your research needs.

    Read our publications, application notes, watch our webinars, or check out the supporting protocols and brochures. All compiled for you, by our scientists.

  • Get inspired by peer-reviewed publications of our scientists, partners, and customers around the globe.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.
  • Any support questions about purchasing, products, or 3D tissue culture and analysis? Get in touch with our experts.

  • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

  • Frequently asked questions answered by our experts. Find here the answer you're looking for.
  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
EN

OrganoReady® Organoid

64 ready-to-use adult stem cell (ASC)-derived organoid tubules for drug exposure, transport, and permeability studies.

Are you interested in dose dependent barrier disruption, and rescue? With the OrganoReady Organoid line, organoids are grown into the OrganoPlate platform as leak tight tubules, allowing you to measure drugs absorption, metabolism and impact on cell health the minute it reaches your lab. Combined with high resolution, quantitative, live microscopy techniques, these cultures require no further optimization.

Our organoid models are derived from adult stem cells (ASCs) whilst most other organoid technologies use embryonic or primary cells. This is a key distinction, as ASC-derived organoids do not require reprogramming or transformation of stem cells. The original properties of the donor, including specific disease aspects, are maintained when cultured outside of the human body. The regenerative capacity of patient-derived ASCs can therefore be utilized to reproduce organ functionality in the lab.



Early Access Program
We offer selected users two fully optimized OrganoReady Organoid models, which are compatible with high throughput screening:

  • The first proliferative organoid-based colon tubules on the market, developed as the next generation platform to characterize the mechanistic toxicology of drugs, or pollutants known to specifically affect this tissue.
  • The first proliferative organoid-based kidney tubules that can be used, for example, to evaluate drug-induced kidney injury in a more translatable way.

Given the more physiological nature of both colon and kidney tubuloids compared to cell lines, primary tissue or iPSC-derived cells, these tubules are the ideal model to not only dissect the mechanistic toxicity of small or large molecules, but also assess their adsorption, metabolism and secretion.

OrganoReady® Organoid package features:

  • 64 ready-to use ASC-derived perfused organoid tubules
  • Recovery Medium and Culture medium
  • ECM: Optimized Collagen-I (Rat Tail)

Product details

Meet the OrganoReady Organoid line

Ready-to-assay organoid tubules
64 ready-to-use kidney and colon organoid tubules seeded against collagen I, allowing you to perform assays right away.

Tailored ASC-derived organoid models
Development of other organoid models such as the small intestine or lung are in the pipeline, with any other tubules requested also at our fingertips. We source any type of epithelial tissue you need. Get in touch to learn more.

Apical and basal access
Polarized and perfused organoid tubules that allow barrier integrity (TEER), transporter, toxicity and permeability assays.

We create the model, so you can focus on your assays
Preparation and QC of OrganoReady Organoids are done by our experts. Use the OrganoReady Organoid models directly after arrival for up to 7 days.

True platform personalization
The first truly personalized ASC-derived Organoid based platform, with all tissue sourced directly from tissue donors and then optimized them to grow into our platform by our scientists.

Early access Kidney and Colon organoids now available.

Contact us

Get inspired


Selected publications

Kidney Tubule-on-a-Chip for Personalized Drug Screening

Culture and Analysis of ASC-derived Kidney Tubuloids

IBD-on-a-Chip for Personalized Drug Screening



Press releases
MIMETAS and Hubrecht Organoid Technology to Develop and Market Organoids-on-a-Chip

MIMETAS Expands Adult Stem Cell Organoid License to All Organs

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules


 

Want to know more?


Get up to speed with 3D tissue culture and learn how OrganoPlate® supports your research needs.

Knowledge Center Contact us

Living innovation

What customers say
'
Our exciting collaboration enables our research and early development group to apply state-of-the-art organ-on-a-chip technology in the modeling of IBD and HBV. These models have the potential to improve our understanding of disease biology and transform

James Sabry, Global Head
Roche Pharma Partnering

The 'I' in Mimetas
Chiwan Chiang
Field Application Specialist
'
A day without
laughter is a day wasted.
Read more
What customers say
'
Mimetas' tumor infiltration platform demonstrated a therapeutic effect of our compound on immune cell recruitment: we’re very excited by these proof of concept data

Scientist
From a top pharma

The 'I' in Mimetas
Jos Joore
CEO
'
We want to
empower research on complex tissue biology.
Read more
What customers say
'
Often you have to compromise it’s either the throughput or it’s the complexity of the model. Getting both in the same platform… no other platform can do that!

Scientist
From a top pharma

The 'I' in Mimetas
Nienke Wevers
Senior Scientist
'
Nothing ventured, nothing gained.
Read more
What customers say
'
We were able to measure cell barrier permeabilities in a lung-on-a-chip model demonstrating superior sensitivity and translatability than any other lung cell model we tried before. It was also very easy to scale up our data generation workflow.

Scientist
From a top commercial organization

The 'I' in Mimetas
Henriëtte Lanz
Director of Model Development
'
It should be
mandatory to
socialize with colleagues.
Read more
What customers say
'
Organoplates opened avenues that were before considered unreachable

Laura Perin, PhD
Children’s Hospital Los Angeles

The 'I' in Mimetas
Bas Trietsch
Chief Technology Officer
'
We try to help
each other
as a team.
Read more
What customers say
'
The OrganoReady model has been very useful for fast screening of novel gene therapy related technologies in our company. The membrane-free fluidics is a high throughput screening tool to monitor a transfer of antibodies through the blood brain barrier.

Svetlana Pasteuning
VectorY B.V., Netherlands

The 'I' in Mimetas
Jacquelien Ten Dam
Chief Financial Officer
'
It always seems impossible until it’s done.
Read more
The 'I' in Mimetas
Paul Vulto
CEO
'
Leveraging who you are, is the key to making a difference!
Read more
Expert Oncology Discussion
'
New Roundtable Discussion



Therapeutic Developments and Innovative Strategies in Oncology: An Expert Discussion
Watch it here

Press Release
'
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-oncology

The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies.

Read the full article here

Grow.Learn.Discover. Event
'
A Decade of Breakthroughs in Human Tissue Modeling

Join us on February, 9th 2023, for our online anniversary event.

Register here

Press Release
'
MIMETAS elected most innovative company of the Netherlands


MIMETAS is the winner of
the Dutch Innovation Award 2022

Read the full article here

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all